MX2023002686A - Derivados de sulfamoil urea que contienen una porcion alquil-oxacicloalquilo y usos de los mismos. - Google Patents
Derivados de sulfamoil urea que contienen una porcion alquil-oxacicloalquilo y usos de los mismos.Info
- Publication number
- MX2023002686A MX2023002686A MX2023002686A MX2023002686A MX2023002686A MX 2023002686 A MX2023002686 A MX 2023002686A MX 2023002686 A MX2023002686 A MX 2023002686A MX 2023002686 A MX2023002686 A MX 2023002686A MX 2023002686 A MX2023002686 A MX 2023002686A
- Authority
- MX
- Mexico
- Prior art keywords
- oxacycloalkyl
- sulphamoyl
- moiety
- containing alkyl
- urea derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074521P | 2020-09-04 | 2020-09-04 | |
| PCT/US2021/049001 WO2022051582A1 (en) | 2020-09-04 | 2021-09-03 | Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023002686A true MX2023002686A (es) | 2023-04-03 |
Family
ID=77951864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023002686A MX2023002686A (es) | 2020-09-04 | 2021-09-03 | Derivados de sulfamoil urea que contienen una porcion alquil-oxacicloalquilo y usos de los mismos. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240043410A1 (enExample) |
| EP (1) | EP4208459A1 (enExample) |
| JP (1) | JP7865948B2 (enExample) |
| KR (1) | KR20230061505A (enExample) |
| CN (1) | CN116783184A (enExample) |
| AR (1) | AR123435A1 (enExample) |
| AU (1) | AU2021336518B2 (enExample) |
| BR (1) | BR112023003792A2 (enExample) |
| CA (1) | CA3191410A1 (enExample) |
| IL (1) | IL301055A (enExample) |
| MX (1) | MX2023002686A (enExample) |
| TW (1) | TWI916398B (enExample) |
| WO (1) | WO2022051582A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201721185D0 (en) | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| HUE067378T2 (hu) | 2019-06-12 | 2024-10-28 | Nodthera Ltd | Szulfonilurea származékok és alkalmazásaik |
| JP7661248B2 (ja) | 2019-06-12 | 2025-04-14 | ノッドセラ リミテッド | スルホニル尿素誘導体及びその使用 |
| KR20260115622A (ko) * | 2023-11-17 | 2026-07-24 | 노드테라 리미티드 | 우레아 유도체의 제조 방법 |
| CN122555701A (zh) | 2023-11-17 | 2026-08-11 | 诺瑟拉有限公司 | 脲衍生物的形式和相关用途 |
| TW202545527A (zh) * | 2024-01-16 | 2025-12-01 | 英商諾得瑟拉公司 | Nlrp3及glp-1a組合療法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| DK1270565T3 (da) | 1997-01-29 | 2004-10-04 | Pfizer | 4-substitueret furan-2-sulfonamid og dets anvendelse i fremstillingen af sulfonylurinstofderivater |
| JP6929792B2 (ja) * | 2015-02-16 | 2021-09-01 | ザ ユニバーシティ オブ クィーンズランド | スルホニル尿素及び関連化合物並びにその使用 |
| JP7412328B2 (ja) | 2017-07-24 | 2024-01-12 | ノバルティス アーゲー | Nlrp活性に関連する状態を治療するための化合物及び組成物 |
| GB201721185D0 (en) * | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| SG11202101480XA (en) | 2018-08-15 | 2021-03-30 | Inflazome Ltd | Novel sulfonamideurea compounds |
-
2021
- 2021-09-03 JP JP2023514910A patent/JP7865948B2/ja active Active
- 2021-09-03 EP EP21778667.2A patent/EP4208459A1/en active Pending
- 2021-09-03 MX MX2023002686A patent/MX2023002686A/es unknown
- 2021-09-03 WO PCT/US2021/049001 patent/WO2022051582A1/en not_active Ceased
- 2021-09-03 CA CA3191410A patent/CA3191410A1/en active Pending
- 2021-09-03 CN CN202180074301.7A patent/CN116783184A/zh active Pending
- 2021-09-03 KR KR1020237011396A patent/KR20230061505A/ko active Pending
- 2021-09-03 AU AU2021336518A patent/AU2021336518B2/en active Active
- 2021-09-03 US US18/043,883 patent/US20240043410A1/en active Pending
- 2021-09-03 AR ARP210102472A patent/AR123435A1/es unknown
- 2021-09-03 IL IL301055A patent/IL301055A/en unknown
- 2021-09-03 TW TW110132880A patent/TWI916398B/zh active
- 2021-09-03 BR BR112023003792A patent/BR112023003792A2/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL301055A (en) | 2023-05-01 |
| CA3191410A1 (en) | 2022-03-10 |
| TWI916398B (zh) | 2026-03-01 |
| BR112023003792A2 (pt) | 2023-03-28 |
| AU2021336518A1 (en) | 2023-03-23 |
| EP4208459A1 (en) | 2023-07-12 |
| AU2021336518B2 (en) | 2026-05-21 |
| AR123435A1 (es) | 2022-11-30 |
| JP2023540733A (ja) | 2023-09-26 |
| US20240043410A1 (en) | 2024-02-08 |
| KR20230061505A (ko) | 2023-05-08 |
| JP7865948B2 (ja) | 2026-05-26 |
| WO2022051582A1 (en) | 2022-03-10 |
| TW202229265A (zh) | 2022-08-01 |
| CN116783184A (zh) | 2023-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202000425B (en) | Selective inhibitors of nlrp3 inflammasome | |
| MX2020006399A (es) | Derivados de sulfonil urea. | |
| MX2025011899A (es) | Compuestos de pirido[4,3-d]pirimidina | |
| BR112023003792A2 (pt) | Derivados de sulfamoil ureia contendo porção alquil-oxacicloalquila e usos dos mesmos | |
| EP4331668A3 (en) | Compounds for inhibiting nlrp3 and uses thereof | |
| MX2022008066A (es) | Compuestos triciclicos sustituidos. | |
| MX2024000234A (es) | Inhibidores del inflamasoma nlrp3. | |
| EA201992152A1 (ru) | Химические соединения | |
| MX2020009738A (es) | Derivados de imidazolidin-2-ona sustituidos como inhibidores de prmt5. | |
| UA86614C2 (ru) | Соединение, которое имеет активность ингибитора киназ, фармацевтическая композиция, которая включает указанное соединение, и их применение для приготовления лекарственного препарата | |
| WO2004071400A3 (en) | Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity | |
| EA201071040A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1, cx3cr1 и p40 | |
| JOP20230252A1 (ar) | مشتقات فسفورية كمثبطات sos1 جديدة | |
| MX2025011886A (es) | Derivados biciclicos semisaturados y usos relacionados | |
| MX2026000683A (es) | Derivados de heteroarilo sustituidos con diaminociclopentilo, su uso y su metodo de preparacion | |
| MX2024014315A (es) | Compuestos amido heteroaromaticos utiles en el tratamiento de enfermedades hepaticas | |
| MY195576A (en) | Novel Amino-Imidazopyridine Derivatives as Janus Kinase Inhibitors and Pharmaceutical use Thereof | |
| WO2025014877A3 (en) | Triazolo wrn inhibitors | |
| MX2025000635A (es) | Compuestos cíclicos y métodos de utilización de estos | |
| CO2024015371A2 (es) | Derivados de oxoindolinil amida para inhibir nlrp3 y usos de los mismos | |
| MX2023012039A (es) | Compuestos bicíclicos fusionados sustituidos como inhibidores de parp y uso de estos. | |
| MX2025001865A (es) | Compuestos de piridinona sustituida como inhibidores de cbl-b | |
| MX2025010952A (es) | Derivados de amida para inhibir el gen nlrp3 y usos de los mismos | |
| MX2021008930A (es) | Derivados de carbamato y sus usos. | |
| WO2024086789A3 (en) | Mutant pi3k-alpha inhibitors and their use as pharmaceuticals |